Matches 1 - 50 out of 185 1 2 3 4 >
Match Document Document Title
7576084 Reverse-turn mimetics and method relating thereto  
Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins are disclosed. Such reverse-turn mimetic structures...
7566711 Reverse-turn mimetics and method relating thereto  
Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins are disclosed. Such reverse-turn mimetic structures...
7507734 Pyridazinone derivatives  
Disclosed are compounds according to the general formula (I), where the definitions of the substituents X, R 1 and R 2 are detailed in the description, as well as their physiologically acceptable...
7473669 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides  
This invention relates to substituted dihydrotriazinones, triazinones and related compounds, compositions comprising such compounds and an agronomically acceptable carrier, and the use thereof as...
7470689 4-benzimidazol-2-ylpyridazin-3-one derivatives  
Disclosed are compounds of the general formula (I), where the definition of the substituents A, B, D, E, R 1 and R 2 are detailed in the description, and the physiologically tolerated salts...
7462615 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications  
The present invention concerns new compounds of formula (I), their process of preparation and their therapeutic use.
7462614 Imidazotriazine compounds  
The present invention provides compounds of formula (I): wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their...
7419978 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors  
Compounds having the formula (I), and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R, R 1 , R 2 , R 5 , R 6a , R 6b , J, K, X and...
7326475 Material for organic electroluminescent device, organic electroluminescent device, illuminating device and display  
The present invention provides: an organic EL element exhibiting high luminance, a high external quantum efficiency and a long high temperature driving life at 50° C.; an illuminator and a display...
7317012 Bicyclic heterocycles as cannabinoind-1 receptor modulators  
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional...
7253167 Tricyclic-heteroaryl compounds useful as kinase inhibitors  
The present invention relates to compounds having the formula, wherein, Q is optionally substituted aryl or heteroaryl, R 1 is hydrogen or C 1-4 alkyl, and R 2 , R 3 , R 4 and R 5 are...
7241763 3-furanyl analogs of toxoflavine as kinase inhibitors  
The present invention concerns the compounds of formula the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein m, n, R 1 , R...
7202243 Substituted imidazotriazines  
The invention relates to new substituted imidazotriazines, processes for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of cancer and...
7199121 Protein tyrosine phosphatase inhibitor  
Use of a compound of formula (I): wherein each R, which are the same or different, is H or C 1 –C 6 alkyl, and X completes a ring which is a substituted triazine having one of the following...
7196095 (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds  
Compounds of formula (I) and pharmaceutically acceptable salts thereof are useful in the treatment of cytokine mediated diseases such as arthritis and in the treatment and/or prevention of...
7176203 Imidazo-triazine derivatives as ligands for gaba receptors  
A class of imidazo[1,2 b ][1,2,4]triazine derivatives, substituted at the 7-position by an optionally substituted five-membered or six-membered heteroaromatic ring, being selective ligands for GABA...
7122548 Triazolotriazine compounds and uses thereof  
The present invention relates to compounds of the Formula (I), and their pharmaceutically acceptable salts. These compounds modulate the activity of c-Met and are therefore expected to be useful in...
7115602 Heterocycles 3  
The invention relates to 7-(4-tert butyl-cyclohexyl)-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory...
7098207 Imidazotriazinones and the use thereof  
Novel imidazotriazinones of general formula a method for the production and the pharmaceutical use thereof are disclosed.
7087605 5-Ethyl-imidazotriazinones  
The invention relates to novel 5-Ethyl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or...
7074790 5-ethylimidarotriazones  
The invention relates to novel 5-ethyl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or...
7037910 Azabicyclic heterocycles as cannabinoid receptor modulators  
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional...
7037909 Tetracyclic compounds as c-Met inhibitors  
The present invention relates to compounds of the Formulae (I) and (II), wherein R 1 -R 10 and G are defined herein, and their pharmaceutically acceptable salts. These compounds modulate the...
7022847 Method for the production of 2-(2-ethoxyphenyl)-substituted imidazotriazinones  
The invention relates to a method for the production of 2-phenyl-substituted imidazotriazinones of general formula (I), comprising the reaction of compounds of formula (II) with compounds of...
7005431 Imidazo-triazine derivatives as ligands for gaba receptors  
A class of 7-phenylimidazo[1,2-b][1,2,4]triazine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or...
6998483 Process for the preparation of sulphonamide-substituted imidazotriazinones  
The present invention relates to a process for the preparation of sulphonamide-substituted imidazotriazinones of the general formula (I) characterized in that compounds of the formula (II) ...
6998402 Substituted imidazotriazinones  
The invention relates to novel substituted imidazotriazinones, to a method for their production and to the use thereof for producing medicaments, in particular to improve perception, powers of...
6984641 Carboline derivatives as PDE5 inhibitors  
Selective inhibitors of cGMP-specific PDE, and use of the compounds and salts and solvates thereof as therapeutic agents, are disclosed.
6977261 Azaisoquinoline derivatives as matrix metalloproteinase inhibitors  
This invention provides compounds defined by Formula I or a pharmaceutically acceptable salt thereof, wherein R 1 , Q, Y, R 2 , R 3 , R 4 , R 5 , and n are as defined in the specification....
6943163 7-Alkyl and cycloalkyl-substituted imidazotriazinones  
The present invention relates to 7-alkyl- and cycloalkyl-substituted imidazotriazinones, to processes for their preparation and to their use as medicaments, in particular as inhibitors of...
6943158 Diazinopyrimidines  
Compounds of formula I are p38 inhibitors: or a pharmaceutically acceptable salt thereof, wherein R 1 is hydrogen or alkyl; R 2 alkyl, haloalkyl, aryl, aralkyl, heteroaryl,...
6936609 Imidazotriazines for use as phosphodiesterase inhibitors  
The invention relates to new imidazotriazines, processes for their preparation, and their use for the production of medicaments for the treatment and/or prophylaxis of neurodegenerative disorders,...
6914060 Imidazotriazinone derivatives as ligands for GABA receptors  
The present invention relates to imidazo[2,1-f]triazin-4-one analogues which are substituted in the 7-position by a substituted phenyl ring, being ligands for GABA A receptors and accordingly of...
6890922 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors  
The 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position are prepared from the corresponding 2-phenyl-imidazotriazinones by chlorosulphonation and...
6878708 Imidazotriazinones and the use thereof  
Novel imidazotriazinones of general formula (I), a method for the production and the pharmaceutical use thereof are disclosed.
6861427 Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists  
Compounds of the formula are useful for treating the cognitive deficits due to aging, stroke, head trauma, Alzheimer's disease or other neurodegenerative diseases, or schizophrenia, and are...
6818641 Arthropodicidal carboxanilides  
Compounds of Formula (I), and their N-oxides and agriculturally suitable salts, are disclosed which are useful as arthropodicides wherein A is H; E is H or C 1 -C 3 alkyl; or A and E can be taken...
6797710 Heterocyclic derivatives and their use as antithrombotic agents  
The present invention relates to antithrombotic compounds comprising the group Q, Q having formula (I), wherein the substructure (i) is a structure selected from (a, b and c), wherein X is O or S;...
6794387 Pharmaceutically active compounds  
Compounds of general formula (I): wherein R 1 , R 2 , R 3 , R 4 , X, Y and A have the meanings given herein which are useful in the curative and prophylactic treatment of a medical condition for...
6770645 Pharmaceutically active compounds  
Compound of general formula I: wherein R 1 , R 2 , R 3 , R 4 , X, Y and R 5 have the meanings given herein which are useful in the curative and prophylactic treatment of a medical condition for...
6740654 Squaric acid derivatives  
Squaric acid derivatives of formula (1) are described: wherein Het is an optionally substituted bicyclic fused ring heteroaromatic group; L 2 is a covalent bond or an atom or group —O—,...
6683081 Triazolotriazinones and the use thereof  
The invention relates to novel triazolotriazinones of the general formula (I), to a method for their production and to the pharmaceutical use thereof.
6664398 Derivatives of erythromycin, their preparation process and their use as medicaments  
A subject of the invention is the compounds of formula in which Y represents a hydrogen atom or a fluorine atom, n represents an integer comprised between 1 and 8, Z represents a hydrogen atom...
6642381 Pyrimido&lsqb 5,4-e&rsqb &lsqb 1,2,4&rsqb triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors  
The invention relates to pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B.
6586429 Tricyclic fused xanthine compounds and their uses  
Novel tricyclic compounds are found to be useful for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling....
6573263 Substituted imidazotriazinones  
The present invention relates to new substituted imidazotriazinones, processes for their preparation, and their use for the production of medicaments, in particular for improving perception,...
6541472 Compounds, compositions and methods for preventing and treating pestivirus infection and associated diseases  
Triazinoindole derivatives are useful in the prophylaxis and treatment of pestivirus infections and diseases associated with pestivirus infections.
6541469 CRF receptor antagonists and methods relating thereto  
CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded...
6525056 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders  
Corticotropin releasing factor (CRF) antagonists of Formula (I): and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress...
6525000 Method for producing anellated triazoles and new anellated triazoles and their use  
A process for preparing fused triazoles of formula I where: X—X is C—O, C—S, C—SO, C—SO 2 , or C—NR 1 ; V is C═W 2 , R 1 R 2 C—C(═W 2 )— or C(═V 2 )—C(═W 2 ); W 1 , W 2...
Matches 1 - 50 out of 185 1 2 3 4 >